Omar Brahim

Omar Brahim has a diverse work experience spanning various companies and roles. Omar currently holds the position of Vice President, FP&A at Mersana Therapeutics, where they have been working since 2020. Prior to this, they held the roles of Executive Director, FP&A and Sr. Director, FP&A at the same company.

Before joining Mersana Therapeutics, Omar worked at TESARO, Inc. from 2016 to 2020. During their time there, they held the positions of Director, Financial Planning & Analysis, Associate Director, FP&A, Commercial & Global Clinical Development, and Sr. Manager, FP&A.

Prior to TESARO, Inc., Omar worked at Seres Therapeutics in 2016 as a Sr. Manager, FP&A. Omar also has experience working at Novartis as the Global Head of Development BPA & MCM Finance and the Head of USG Finance.

Before that, Omar worked at CDM Smith as the Manager of Government Audits, where they were responsible for developing corporate indirect rates and managing all external audit activity.

Omar's early career includes a role at iRobot as a Finance Manager and at PricewaterhouseCoopers as a Senior Associate, where they were involved in financial effectiveness project engagements.

Overall, Omar Brahim has extensive experience in financial planning and analysis, with a focus on the pharmaceutical and biotech industry.

Omar Brahim completed their Master of Business Administration (MBA) degree at the University of Massachusetts Lowell in 2016. Prior to that, they attended Merrimack College from 2001 to 2004.